Lotus Pharmaceutical Co., Ltd. (TPE:1795)
220.50
-3.50 (-1.56%)
Apr 29, 2026, 1:30 PM CST
2.80% (1Y)
| Market Cap | 58.87B |
| Revenue (ttm) | 20.51B |
| Net Income (ttm) | 4.72B |
| Shares Out | 262.81M |
| EPS (ttm) | 18.04 |
| PE Ratio | 12.42 |
| Forward PE | 13.89 |
| Dividend | 2.56 (1.16%) |
| Ex-Dividend Date | Aug 11, 2025 |
| Volume | 1,839,015 |
| Average Volume | 2,691,394 |
| Open | 226.50 |
| Previous Close | 224.00 |
| Day's Range | 220.50 - 226.50 |
| 52-Week Range | 185.00 - 369.50 |
| Beta | 0.52 |
| RSI | 45.04 |
| Earnings Date | May 7, 2026 |